SCI Abstract

search
+
Correction: Extended LUTS medication use following BPH surgical treatment: a US healthcare claims analysis
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which...
Treatment cycles per unit prostate volume (CPV) for transurethral water vapor therapy (Rezūm) in catheter-dependent patients
For transurethral water vapor therapy (Rezūm), the number of water vapor treatment cycles has classically been determ...
Perioperative outcomes of HoLEP, ThuLEP, and TURP in patients with prostate cancer: results from the GRAND study
Perioperative outcomes of HoLEP, ThuLEP, and TURP in patients with prostate cancer: results from the GRAND study
Limited data exist on the role of holmium laser enucleation of the prostate (HoLEP), thulium laser enucleation of the pros...
MISTs for benign prostatic hyperplasia as first line interventional treatment: Alea iacta est?
MISTs for benign prostatic hyperplasia as first line interventional treatment: Alea iacta est?
Elterman D, Kaplan SA. Reimagining male lower urinary tract symptoms due to benign prostatic hyperplasia treatment: a new ...
Feasibility and safety study of the Flostent™ system (RAPID-I)
Feasibility and safety study of the Flostent™ system (RAPID-I)
This study aimed to evaluate the feasibility and safety of the FloStent™, a novel nitinol prostatic stent, in men wi...
New BPH therapy classification: what really FITs?
The prevalence of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) increases with age. ...
Abiraterone for “STAMPEDE-Like” cohort of high-risk prostate cancer in the PSMA-PET era: too much, too early?
Abiraterone for “STAMPEDE-Like” cohort of high-risk prostate cancer in the PSMA-PET era: too much, too early?
To assess long-term survival in a “STAMPEDE-like” cohort of high-risk locally advanced prostate cancer, staged...
Toward a holistic understanding of Metformin’s Role in oncology: responding to methodological limitations and enhancing translational relevance
TO THE EDITOR:We read with great interest the recent article entitled “ Effect of metformin on incidence, recurrence, and ...
Correction: Retreatment rates and postprocedural complications are higher than expected after BPH surgeries: a US healthcare claims and utilization study
The article Retreatment rates and postprocedural complications are higher than expected after BPH surgeries: a US healthca...
The effects of glycemic index on prostate cancer progression in a xenograft mouse model
The effects of glycemic index on prostate cancer progression in a xenograft mouse model
Previously, we found low-carbohydrate diets slowed prostate cancer (PC) growth and increased survival vs. a Western diet i...
High-risk biochemical recurrence of locally treated prostate cancer after EMBARK. An end to decades of conventional wisdom?
Managing biochemical recurrence (BCR) of localized prostate cancers (PCa) that have failed all option...
Real-world prevalence of homologous recombination repair mutations in advanced prostate cancer: an analysis of two clinico-genomic databases
Real-world prevalence of homologous recombination repair mutations in advanced prostate cancer: an analysis of two clinico-genomic databases
Homologous recombination repair mutation (HRRm) status may guide risk-stratification and treatment decisions, including po...
Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer
Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer
Identification of emerging molecular biomarkers on circulating tumor cells (CTCs) represents an attractive feature of liqu...
Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: a retrospective cohort study
Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: a retrospective cohort study
While the cardiovascular risks of androgen receptor pathway inhibitors have been studied, they were seldom compared direct...
Impact of medical treatment on storage and voiding LUTS, nocturia, and quality of life in men at risk for progression
Prostate enlargement is a very common pathologic condition [1]: male aging process is associated with...
Reevaluating ‘Top-Down’ HoLEP: the case for anterior fibromuscular stroma as a surgical landmark
Elmansy H, Abbas L, Fathy M, Hodhod A, Shabana W, Alkandari A, et al. Top-down holmium laser enucleation of the prostate (...
The relative impact of lymph-node metastasis and seminal vesical invasion on oncologic outcomes following radical prostatectomy
Rodrigues Pessoa R, Nabavizadeh R, Shah P, Frank I, Tollefson M, Sharma V et al. Relative Impact of Lymph-node Metastasis ...
Comparison of 18F-based PSMA radiotracers with [68Ga]Ga-PSMA-11 in PET/CT imaging of prostate cancer—a systematic review and meta-analysis
Comparison of 18F-based PSMA radiotracers with [68Ga]Ga-PSMA-11 in PET/CT imaging of prostate cancer—a systematic review and meta-analysis
Prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) has become an increa...
Comparison of procedural anxiety and pain associated with conventional transrectal ultrasound prostate biopsy to magnetic resonance imaging-ultrasound fusion-guided biopsy: a prospective cohort trial
Comparison of procedural anxiety and pain associated with conventional transrectal ultrasound prostate biopsy to magnetic resonance imaging-ultrasound fusion-guided biopsy: a prospective cohort trial
Prostate cancer (PCa) diagnosis relies on biopsies, with transrectal ultrasound (TRUS) biopsies being common. Fusion biops...
High GLUT1 membrane expression and low PSMA membrane expression in Ductal Adenocarcinoma and Intraductal Carcinoma of the prostate
High GLUT1 membrane expression and low PSMA membrane expression in Ductal Adenocarcinoma and Intraductal Carcinoma of the prostate
Both Ductal Adenocarcinoma (DAC) and Intraductal Carcinoma (IDC) of the prostate are generally associated with aggressive ...
Is there a role for radical prostatectomy in the management of oligometastatic prostate cancer? A systematic review
Is there a role for radical prostatectomy in the management of oligometastatic prostate cancer? A systematic review
There is a growing interest about the role of radical prostatectomy (RP) in local cancer control in oligometastatic prosta...
Shifting the paradigm in high-risk prostate cancer: how good is TNM alone?
McKay RR, Montgomery B, Xie W, Zhang Z, Bubley GJ, Lin DW, et al. Post prostatectomy outcomes of patients with high-risk p...
Digital informed consent for urological surgery - randomized controlled study comparing multimedia-supported vs. traditional paper-based informed consent concerning satisfaction, anxiety, information gain and time efficiency
Digital informed consent for urological surgery - randomized controlled study comparing multimedia-supported vs. traditional paper-based informed consent concerning satisfaction, anxiety, information gain and time efficiency
Due to a lack of time and staff, informed consent (IC) in clinical practice often lacks clarity, comprehensibility and sco...
Editorial: new horizons in robotic platforms
Editorial: new horizons in robotic platforms
At the beginning of the 21st century, the first Intuitive Surgical Da Vinci system was introduced. Histor...
External validation of nomograms including MRI features for the prediction of side-specific extraprostatic extension
External validation of nomograms including MRI features for the prediction of side-specific extraprostatic extension
Prediction of side-specific extraprostatic extension (EPE) is crucial in selecting patients for nerve-sparing radical pros...
Early PSA decline after starting second-generation hormone therapy in the post-docetaxel setting predicts cancer-specific survival in metastatic castrate-resistant prostate cancer
Early PSA decline after starting second-generation hormone therapy in the post-docetaxel setting predicts cancer-specific survival in metastatic castrate-resistant prostate cancer
The objective of this study was to evaluate the prognostic value of early PSA decline following initiation of second-gener...
ChatGPT in prostate cancer: myth or reality?
Chat.OpenAI is an AI-powered platform that provides a natural language processing (NLP) interface for bui...
Correction: Hormonal treatment for newly diagnosed metastatic prostate cancer: a population-based study from the California cancer registry
Correction to: Prostate Cancer and Prostatic Diseases https://doi.org/10.1038/s41391-023-00732-9, publish...
Comparative analysis of robot-assisted simple prostatectomy: the HUGO™ RAS system versus the DaVinci® Xi system
Comparative analysis of robot-assisted simple prostatectomy: the HUGO™ RAS system versus the DaVinci® Xi system
Robot-Assisted Simple Prostatectomy (RASP) has emerged as a promising alternative in the treatment of benign prostatic obs...
Developers-Doctor-patients: the artificial intelligence’s trifecta
Artificial Intelligence (AI) is now a reality that can no longer be denied, all people have heard of it, ...
Load More
format_indent_increase